The development of advanced pharmaceuticals relies heavily on the precise synthesis of complex molecules. At the heart of this process lies the careful selection and utilization of chemical intermediates. For the veterinary pharmaceutical sector, the Afoxolaner Intermediate, identified by its CAS number 1308362-48-2, represents a crucial building block. NINGBO INNO PHARMCHEM CO.,LTD. specializes in providing such vital compounds, ensuring that the industry has access to materials of the highest caliber for their synthesis needs.
The Afoxolaner Intermediate is characterized by its specific chemical structure: C22H12ClF6NO3, with a molecular weight of 487.78. This precise molecular blueprint is what makes it indispensable in the synthesis pathway for Afoxolaner, a powerful ectoparasiticide widely used in companion animal health. The intermediate serves as a stable precursor, allowing for controlled chemical transformations to yield the final active pharmaceutical ingredient (API). The purity of this intermediate, stated as >98%, is a critical factor for the efficiency and success of subsequent synthesis steps, aligning with the principles of organic chemical synthesis solutions.
NINGBO INNO PHARMCHEM CO.,LTD. places a strong emphasis on quality assurance, ensuring that its Afoxolaner Intermediate meets stringent industry standards. Certifications such as GMP (Good Manufacturing Practice), ISO 9001, and FDA compliance underscore the company's commitment to producing intermediates that are not only chemically precise but also manufactured under rigorous quality management systems. This adherence is vital for companies involved in veterinary API intermediates, as it guarantees the integrity and safety of the final veterinary drug products.
The application of this intermediate extends beyond large-scale manufacturing. It is also utilized as a reliable chemical synthesis laboratory reagent, supporting research and development efforts. Scientists and chemists use such intermediates to explore new synthetic routes, develop novel compounds, or conduct analytical studies. The availability of well-characterized intermediates facilitates faster innovation and process optimization within the pharmaceutical R&D landscape.
For companies engaged in the complex field of pharmaceutical manufacturing, reliable custom chemical synthesis services are often required. NINGBO INNO PHARMCHEM CO.,LTD. understands the bespoke needs of the industry and provides consistent access to high-quality intermediates. By focusing on specific chemical compounds like the Afoxolaner Intermediate, they contribute significantly to the robustness of the pharmaceutical supply chain for veterinary medicines.
In summary, the Afoxolaner Intermediate (CAS 1308362-48-2) is a fundamental component in the creation of modern veterinary pharmaceuticals. NINGBO INNO PHARMCHEM CO.,LTD.'s dedication to providing this high-purity, certified intermediate highlights the essential role of specialized chemical suppliers in advancing animal health through precise chemical manufacturing and reliable fine chemical sourcing.
Manufacturing Facilities






Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.